(1 - 9 von 9
)
KINAXO Announces Agreement with Johnson & Johnson | More ...
pipelinereview.com
· KINAXO is a spin-off from the Max Planck Institute of Biochemistry in Martinsried, initiated by Prof. Dr. Axel Ullrich and Dr. Henrik Daub as well as Max Planck Innovation GmbH, the technology transfer center of the Max Planck Society. KINAXO offers a comprehensive chemical proteomics technology - known as KinaTorTM - to identify and characterize the biological interaction of small …
Kinaxo gets grant for drug-protein interaction technology | Science ...sciencebusiness.net › news › Kinaxo-gets-grant-for-...
sciencebusiness.net
... collaborators, Dr Lothar Jänsch of the Helmholtz Institute in Braunschweig and Dr Henrik Daub of the Max Planck Institute for Biochemistry in Martinsried.
sortiert nach Relevanz / Datum